In the News: November 8–November 15
By Sg2 TeamThis week: Liquid biopsy tests for cancer care move into the mainstream; midterm elections prove consequential to Medicaid; and CVS Health to expand services into chronic disease management.
- Share
This week: Liquid biopsy tests for cancer care move into the mainstream; midterm elections prove consequential to Medicaid; and CVS Health to expand services into chronic disease management.
This week: States are creating ACOs for Medicaid recipients to control costs; AMA announced their opposition to Aetna–CVS Merger; and health systems are using technology solutions to appeal to consumers.
A few weeks into the new year, I find myself contemplating a quote from the American poet Mark Strand, who once said, “The future is always beginning now.” This statement...
A conveyer belt of bad news has ceaselessly flowed toward Palo Alto–based Theranos over the past month. If you’ve lost track of the story, the company aims to disrupt the...
Are you being disrupted? Are you disrupting yourself, your market or your competitors? Are you asking the critical “what if” questions that will guide your future? If not, you should...
Brainpower is one of health care’s most valuable and abundant resources, but harnessing that power is a constant struggle. Attempts can become bogged down in the quagmire of competing priorities,...
"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."